Insiders Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			Pre-market 07:05:00 am
455.3 ^USD	+2.74%		456.9	+0.34%

May. 31	BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480	MT
May. 31	Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	May. 31	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $715,205, According to a Recent SEC Filing	May. 29	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing	May. 24	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing	May. 22	MT
Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director	May. 15	CI
Vertex Pharmaceuticals Insider Sold Shares Worth $2,142,974, According to a Recent SEC Filing	Feb. 27	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $506,546, According to a Recent SEC Filing	Feb. 23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,519,637, According to a Recent SEC Filing	Feb. 23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,776,528, According to a Recent SEC Filing	Feb. 16	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $727,822, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,804,931, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $383,679, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,321,655, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $577,410, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,785,977, According to a Recent SEC Filing	Jan. 10	MT
Shield Therapeutics hires former Akili leader as new CFO	Jan. 09	AN
Vertex Pharmaceuticals Insider Sold Shares Worth $1,215,000, According to a Recent SEC Filing	Jan. 04	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $6,973,945, According to a Recent SEC Filing	Dec. 19	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $5,333,799, According to a Recent SEC Filing	Dec. 15	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,023,906, According to a Recent SEC Filing	Dec. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST